Anna Eisert

K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways

Matthias Scheffler, Michaela A. Ihle, Rebecca Hein et al. · Journal of Thoracic Oncology · 2018 · 259 citations · Full text

Medicine, Genetics, Oncology +17

Clinical and Pathological Characteristics of <i>KEAP1</i> - and <i>NFE2L2</i> -Mutated Non–Small Cell Lung Carcinoma (NSCLC)

Rieke Frank, Matthias Scheffler, Sabine Merkelbach‐Bruse et al. · Clinical Cancer Research · 2018 · 166 citations

Medicine, Genetics, Oncology +17

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

Mihaela Aldea, Arianna Marinello, M. Duruisseaux et al. · Journal of Thoracic Oncology · 2023 · 48 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors

Richard Riedel, Jana Fassunke, Hannah L. Tumbrink et al. · European Journal of Cancer · 2022 · 29 citations

Medicine, Medicinal Chemistry, Pharmacology +10

MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition

Richard Riedel, Jana Fassunke, Andreas H. Scheel et al. · Journal of Thoracic Oncology · 2023 · 19 citations · Full text

Medicine, Molecular Medicine, Oncology +8